About Semaglutide
Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Clinical trials demonstrate significant reductions in body weight and cardiovascular risk markers. It works by enhancing insulin secretion, suppressing glucagon, and reducing appetite.
Semaglutide & Type 2 Diabetes
Semaglutide is FDA-approved as Ozempic for type 2 diabetes management. It is a GLP-1 receptor agonist that enhances insulin secretion and suppresses glucagon. It is one of the most extensively studied peptides available.
Content sourced from existing TruthTides clinical reference documentation. This is informational only. Consult a qualified physician.
Find a Semaglutide prescriber in Chicago
Browse qualified physicians who prescribe Semaglutide in the Chicago area, or search nationwide via telehealth.
Ask TruthSource AI
Ask anything about Semaglutide for Type 2 Diabetes
Get a guardrailed, evidence-anchored answer from our clinical reference tool.
Open Reference ToolFind a Doctor
Search verified Semaglutide prescribers nationwide
Filter by peptide, location, and telehealth availability.
Open Physician FinderSemaglutide for Type 2 Diabetes in Other Cities
This content is sourced from existing TruthTides clinical reference documentation. It does not constitute medical advice or treatment recommendations. Consult a qualified physician before starting any peptide therapy.